A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia

Neuroinformatics

Volumn 12, Issue 4, 2014, Pages 575-593

  Della Rosa, Pasquale Anthony ^a   Cerami, Chiara ^b,c   Gallivanone, Francesca ^a   Prestia, Annapaola ^d   Caroli, Anna ^e   Castiglioni, Isabella ^a   Gilardi, Maria Carla ^a,f   Frisoni, Giovanni ^d,g   Friston, Karl ^h   Ashburner, John ⁱ   Perani, Daniela ^b,c  

^a INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ WELLCOME TRUST CENTRE FOR NEUROIMAGING   (United Kingdom)

Author keywords

18F FDG PET; Dementia; Spatial normalization; SPM (RRID:nif 0000 00343); Template

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; DEMENTIA; FEMALE; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PSYCHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 84911007865     PISSN: 15392791     EISSN: 15590089     Source Type: Journal    
DOI: 10.1007/s12021-014-9235-4     Document Type: Article

References (54)

1. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270–279.
2. Anchisi, D., Borroni, B., Franceschi, M., Kerrouche, N., Kalbe, E., Beuthien-Beumann, B., Cappa, S., et al. (2005). Heterogeneity of brain glucose metaboism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology, 62(11), 1728–1733.
3. Ashburner, J. (2007). A fast diffeomorphic image registration algorithm. NeuroImage, 38(1), 95–113.
4. Ashburner, J., & Friston, K. J. (1999). Nonlinear spatial normalization using basis functions. Human Brain Mapping, 7(4), 254–266.
5. Bartenstein, P., Asenbaum, S., Catafau, A., Halldin, C., Pilowski, L., Pupi, A., et al. (2002). European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. European Journal of Nuclear Medicine and Molecular Imaging, 29(10), BP43–BP48.
6. Berti, V., Osorio, R. S., Mosconi, L., Li, Y., De Santi, S., & de Leon, M. J. (2010). Early detection of Alzheimer’s disease with PET imaging. Neurodegenerative Diseases, 7(1–3), 131–135.
7. Bornebroek, M., & Bretelera, M. B. (2004). Epidemiology of non-AD dementia. Clinical Neuroscience Reserach, 3, 349–361.
8. Buchert, R., Wilke, F., Chakrabarti, B., Martin, B., Brenner, W., Mester, J., & Clausen, M. (2005). Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer’s disease. Journal of Neuroimaging, 15, 348–355.
9. Caroli, A., Prestia, A., Chen, K., Ayutyanont, N., Landau, S. M., Madison, C. M., et al. (2012). Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. Journal of Nuclear Medicine, 53(4), 592–600.
10. Chételat, G., Desgranges, B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J. C. (2003). Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology, 60(8), 1374–1377.
11. Crivello, F., Schormann, T., Tzourio-Mazoyer, N., Roland, P. E., Zilles, K., & Mazoyer, B. M. (2002). Comparison of spatial normalization procedures and their impact on functional maps. Human Brain Mapping, 16(4), 228–250.
12. Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., Dekosky, S. T., Barberger-Gateau, P., et al. (2010). Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurology, 9(11), 1118–1127.
13. Eickhoff, S., Stephan, K. E., Mohlberg, H., Grefkes, C., Fink, G. R., Amunts, K., et al. (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage, 25(4), 1325–1335.
14. Evans, A. C., Collins, D. L., Mills, S. R., Brown, E. D., Kelly, R. L., & Peters, T. M. (1993). 3D statistical neuroanatomical models from 305 MRI volumes. IEEE-Nuclear Science Symposium and Medical Imaging Conference Proceeding, 1813–1817.
15. Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., et al. (2007). FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain, 130(Pt10), 2616–2635.
16. Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. P., Frith, C. D., & Frackowiak, R. S. (1994). Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping, 2(4), 189–210.
17. Gispert, J. D., Pascau, J., Reig, S., Martinez-Lazaro, R., Molina, V., Garcia-Barreno, P., et al. (2003). Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. NeuroImage, 19(3), 601–612.
18. Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., & Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage, 14(1 Pt1), 21–36.
19. Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., et al. (2002). Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage, 17(1), 302–316.
20. Ishii, K., Willoch, F., Minoshima, S., Drzezga, A., Ficaro, E. P., Cross, D. J., et al. (2001). Statistical brain mapping of 18F-FDG PET in Alzheimer’s disease: validation of anatomic standardization for atrophied brains. Journal of Nuclear Medicine, 42(4), 548–557.
21. Jack, C. R., Jr., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., et al. (2011). Introduction to the recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 257–262.
22. Kherif, F., Poline, J. P., Mériaux, S., Benali, H., Flandin, G., & Brett, M. (2003). Group analysis in functional neuroimaging: selecting subjects using similarity measures. NeuroImage, 20(4), 2197–2208.
23. Krishnan, S., Slavin, M. J., Tran, T. T., Doraiswamy, P. M., & Petrella, J. R. (2006). Accuracy of spatial normalization of the hippocampus: implications for fMRI research in memory disorders. NeuroImage, 31(2), 560–571.
24. Magistretti, P. J. (2000). Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Research, 886(1–2), 108–112.
25. Markiewicz, P. J., Matthews, J. C., Declerck, J., & Herholz, K. (2009). Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer’s disease. NeuroImage, 46(2), 472–485.
26. Martino, M. E., Guzman de Villoria, J., Lacalle-Aurioles, M., Olazaran, J., Cruz, I., Navarro, E., et al. (2013). Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls. Annals of Nuclear Medicine. doi:10.1007/s12149-013-0723-7.
27. McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12), 1863–1872.
28. McKhann, G. M., Albert, M. S., Grossman, M., Miller, B., Dickson, D., & Trojanowski, J. Q. (2001). Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Archives of Neurology, 58, 1803–1809.
29. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., Klunk, W. E., et al. (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging– Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269.
30. Minoshima, S., Frey, K. A., Koeppe, R. A., Foster, N. L., & Kuhl, D. E. (1995). A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Journal of Nuclear Medicine, 36(7), 1238–1248.
31. Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997). Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Annals of Neurology, 42(1), 85–94.
32. Minoshima, S., Foster, N. L., Sima, A. A., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001). Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology, 50(3), 358–365.
33. Morbelli, S., Drzezga, A., Perneczky, R., Frisoni, G. B., Caroli, A., van Berckel, B. N., et al. (2012). Resting metabolic connectivity in prodromal Alzheimer’s disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiology of Aging, 33(11), 2533–2550.
34. Mori, T., Ikeda, M., Fukuhara, R., Nestor, P. J., & Tanabe, H. (2006). Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology, 66(6), 935–937.
35. Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., et al. (2008). Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. Journal of Nuclear Medicine, 49(3), 390–398.
36. Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., et al. (1998). Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546–1554.
37. Patterson, J. C., Lilien, D. L., Takalkar, A., & Pinkston, J. B. (2011). Early detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans. International Journal of Alzheimer’s Disease. doi:10.4061/2011/946590.
38. Perani, D. (2008). Functional neuroimaging of cognition. In: M. J. Aminoff, F. Boller, & D. F. Swaab (Eds.), Handbook of Clinical Neurology (pp.61–111). Elsevier.
39. Prince, M., Bryce, R., & Ferr, C. (2011). The benefits of early diagnosis and intervention. In: Alzheimer’s Disease International World Alzheimer Report 2011. Institute of Psychiatry. King’s College London. Alzheimer’s Disease International.
40. Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., et al. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(Pt9), 2456–2477.
41. Ridgway, G., Omar, R., Ourselin, S., Hill, D., Warren, J., & Fox, N. (2009). Issues with threshold masking in voxel-based morphometry of atrophied brains. NeuroImage, 44(1), 99–111.
42. Rorden, C., Bonilha, L., Fridriksson, J., Bender, B., & Karnath, H. O. (2012). Age-specific CT and MRI templates for spatial normalization. NeuroImage, 61(4), 957–965.
43. Salmon, E., Garraux, G., Delbeuck, X., Collette, F., Kalbe, E., Zuendorf, G., et al. (2003). Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. NeuroImage, 20(1), 435–440.
44. Salmon, E., Kerrouche, N., Perani, D., Lekeu, F., Holthoff, V., Beuthien- Baumann, B., et al. (2009). On the multivariate nature of brain metabolic impairment in Alzheimer’s disease. Neurobiology of Aging, 30(2), 186–197.
45. Sestini, S., Castagnoli, A., & Mansi, L. (2010). The new FDG brain revolution: the neurovascular unit and the default network. European Journal of Nuclear Medicine and Molecular Imaging, 37(5), 913–916.
46. Signorini, M., Paulesu, E., Friston, K., Perani, D., Colleluori, A., Lucignani, G., et al. (1999). Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. NeuroImage, 9(1), 63–80.
47. Spence, J. S., Carmack, P. S., Gunst, R. F., Schucany, W. R., Woodward, W. A., & Haley, R. W. (2006). Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses. NeuroImage, 32(1), 49–53.
48. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Towards defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 280–292.
49. Teipel, S. J., Sabri, O., Grothe, M., Barthel, H., Prvulovic, D., Buerger, K., et al. (2013). Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer’s disease. Journal of Alzheimer’s Disease, 33(S1), S329–S347.
50. Teune, L. K., Bartels, A. L., de Jong, B. M., Willemsen, A. T., Eshuis, S. A., de Vries, J. J., et al. (2010). Typical cerebral metabolic patterns in neurodegenerative brain diseases. Movement Disorders, 25(14), 2395–2404.
51. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273–289.
52. Wenzel, F., Young, S., Wilke, F., Apostolova, I., Arlt, S., Jahn, H., et al. (2010). B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis. NeuroImage, 50(3), 994–1003.
53. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256(3), 240–246.
54. Yakushev, I., Hammers, A., Fellgiebel, A., Schmidtmann, I., Scheurich, A., Buchholz, H. G., et al. (2009). SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnesic mild cognitive impairment from healthy aging. NeuroImage, 44(1), 43–50.